Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Net Income (Loss) Attributable to Noncontrolling Interest

1.8 / 5 stars · 42/120 Roast Me

GILEAD SCIENCES, INC. Net Income (Loss) Attributable to Noncontrolling Interest

GILEAD SCIENCES, INC. (GILD) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-02-24

  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-03-31 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $0.00.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$52.00M.
  • GILEAD SCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$26.00M.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$0.00
derived: sum of 2 quarters · filed 2026-02-24
$0.00
derived: sum of 3 quarters · filed 2026-02-24
$0.00
10-K · filed 2026-02-24
2025-09-30$0.00
10-Q · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
$0.00
derived: sum of 4 quarters · filed 2026-02-24
2025-06-30$0.00
10-Q · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2026-02-24
$0.00
derived: sum of 4 quarters · filed 2026-02-24
2025-03-31$0.00
10-Q · filed 2025-05-07
$0.00
derived: sum of 2 quarters · filed 2026-02-24
$0.00
derived: sum of 3 quarters · filed 2026-02-24
$0.00
derived: sum of 4 quarters · filed 2026-02-24
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$0.00
derived: sum of 2 quarters · filed 2026-02-24
$0.00
derived: sum of 3 quarters · filed 2026-02-24
$0.00
10-K · filed 2026-02-24
2024-09-30$0.00
10-Q · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
-$12.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$0.00
10-Q · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
-$12.00M
derived: sum of 3 quarters · filed 2026-02-24
-$20.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$0.00
10-Q · filed 2025-05-07
-$12.00M
derived: sum of 2 quarters · filed 2026-02-24
-$20.00M
derived: sum of 3 quarters · filed 2026-02-24
-$26.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$12.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$20.00M
derived: sum of 2 quarters · filed 2026-02-24
-$26.00M
derived: sum of 3 quarters · filed 2026-02-24
-$52.00M
10-K · filed 2026-02-24
2023-09-30-$8.00M
10-Q · filed 2024-11-12
-$14.00M
derived: sum of 2 quarters · filed 2024-11-12
-$40.00M
10-Q · filed 2024-11-12
-$47.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$6.00M
10-Q · filed 2024-08-08
-$32.00M
10-Q · filed 2024-08-08
-$39.00M
derived: sum of 3 quarters · filed 2025-02-28
-$42.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$26.00M
10-Q · filed 2024-05-08
-$33.00M
derived: sum of 2 quarters · filed 2025-02-28
-$36.00M
derived: sum of 3 quarters · filed 2025-02-28
-$45.00M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$10.00M
derived: sum of 2 quarters · filed 2025-02-28
-$19.00M
derived: sum of 3 quarters · filed 2025-02-28
-$26.00M
10-K · filed 2025-02-28
2022-09-30-$3.00M
10-Q · filed 2023-11-07
-$12.00M
derived: sum of 2 quarters · filed 2023-11-07
-$19.00M
10-Q · filed 2023-11-07
-$25.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30-$9.00M
10-Q · filed 2023-08-04
-$16.00M
10-Q · filed 2023-08-04
-$22.00M
derived: sum of 3 quarters · filed 2024-02-23
-$28.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31-$7.00M
10-Q · filed 2023-05-03
-$13.00M
derived: sum of 2 quarters · filed 2024-02-23
-$19.00M
derived: sum of 3 quarters · filed 2024-02-23
-$24.00M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31-$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
-$12.00M
derived: sum of 2 quarters · filed 2024-02-23
-$17.00M
derived: sum of 3 quarters · filed 2024-02-23
-$24.00M
10-K · filed 2024-02-23
2021-09-30-$6.00M
10-Q · filed 2022-11-02
-$11.00M
derived: sum of 2 quarters · filed 2022-11-02
-$18.00M
10-Q · filed 2022-11-02
-$25.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$5.00M
10-Q · filed 2022-08-08
-$12.00M
10-Q · filed 2022-08-08
-$19.00M
derived: sum of 3 quarters · filed 2023-02-22
-$26.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31-$7.00M
10-Q · filed 2022-05-04
-$14.00M
derived: sum of 2 quarters · filed 2023-02-22
-$21.00M
derived: sum of 3 quarters · filed 2023-02-22
-$28.00M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$14.00M
derived: sum of 2 quarters · filed 2023-02-22
-$21.00M
derived: sum of 3 quarters · filed 2023-02-22
-$34.00M
10-K · filed 2023-02-22
2020-09-30-$7.00M
10-Q · filed 2021-11-03
-$14.00M
derived: sum of 2 quarters · filed 2021-11-03
-$27.00M
10-Q · filed 2021-11-03
-$34.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$7.00M
10-Q · filed 2021-08-05
-$20.00M
10-Q · filed 2021-08-05
-$27.00M
derived: sum of 3 quarters · filed 2022-02-23
-$30.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$13.00M
10-Q · filed 2021-05-06
-$20.00M
derived: sum of 2 quarters · filed 2022-02-23
-$23.00M
derived: sum of 3 quarters · filed 2022-02-23
-$28.00M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$10.00M
derived: sum of 2 quarters · filed 2022-02-23
-$15.00M
derived: sum of 3 quarters · filed 2022-02-23
-$22.00M
10-K · filed 2022-02-23
2019-09-30-$3.00M
10-Q · filed 2020-11-04
-$8.00M
derived: sum of 2 quarters · filed 2020-11-04
-$15.00M
10-Q · filed 2020-11-04
-$15.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$5.00M
10-Q · filed 2020-08-06
-$12.00M
10-Q · filed 2020-08-06
-$12.00M
derived: sum of 3 quarters · filed 2021-02-25
-$10.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$7.00M
10-Q · filed 2020-05-06
-$7.00M
derived: sum of 2 quarters · filed 2021-02-25
-$5.00M
derived: sum of 3 quarters · filed 2021-02-25
-$3.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$2.00M
derived: sum of 2 quarters · filed 2021-02-25
$4.00M
derived: sum of 3 quarters · filed 2021-02-25
$5.00M
10-K · filed 2021-02-25
2018-09-30$2.00M
10-Q · filed 2019-11-05
$4.00M
derived: sum of 2 quarters · filed 2019-11-05
$5.00M
10-Q · filed 2019-11-05
$34.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$2.00M
10-Q · filed 2019-08-06
$3.00M
10-Q · filed 2019-08-06
$32.00M
derived: sum of 3 quarters · filed 2020-02-25
$26.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$1.00M
10-Q · filed 2019-05-08
$30.00M
derived: sum of 2 quarters · filed 2020-02-25
$24.00M
derived: sum of 3 quarters · filed 2020-02-25
$20.00M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$29.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$23.00M
derived: sum of 2 quarters · filed 2020-02-25
$19.00M
derived: sum of 3 quarters · filed 2020-02-25
$16.00M
10-K · filed 2020-02-25
2017-09-30-$6.00M
10-Q · filed 2018-11-06
-$10.00M
derived: sum of 2 quarters · filed 2018-11-06
-$13.00M
10-Q · filed 2018-11-06
-$22.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$4.00M
10-Q · filed 2018-08-06
-$7.00M
10-Q · filed 2018-08-06
-$16.00M
derived: sum of 3 quarters · filed 2019-02-26
-$21.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$3.00M
10-Q · filed 2018-05-09
-$12.00M
derived: sum of 2 quarters · filed 2019-02-26
-$17.00M
derived: sum of 3 quarters · filed 2019-02-26
-$17.00M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$14.00M
derived: sum of 2 quarters · filed 2019-02-26
-$14.00M
derived: sum of 3 quarters · filed 2019-02-26
-$13.00M
10-K · filed 2019-02-26
2016-09-30-$5.00M
10-Q · filed 2017-11-07
-$5.00M
derived: sum of 2 quarters · filed 2017-11-07
-$4.00M
10-Q · filed 2017-11-07
-$2.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$0.00
10-Q · filed 2017-08-07
$1.00M
10-Q · filed 2017-08-07
$3.00M
derived: sum of 3 quarters · filed 2018-02-27
-$5.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$1.00M
10-Q · filed 2017-05-10
$3.00M
derived: sum of 2 quarters · filed 2018-02-27
-$5.00M
derived: sum of 3 quarters · filed 2018-02-27
$0.00
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$6.00M
derived: sum of 2 quarters · filed 2018-02-27
-$1.00M
derived: sum of 3 quarters · filed 2018-02-27
-$2.00M
10-K · filed 2018-02-27
2015-09-30-$8.00M
10-Q · filed 2016-11-07
-$3.00M
derived: sum of 2 quarters · filed 2016-11-07
-$4.00M
10-Q · filed 2016-11-07
-$29.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$5.00M
10-Q · filed 2016-08-05
$4.00M
10-Q · filed 2016-08-05
-$21.00M
derived: sum of 3 quarters · filed 2017-02-27
-$28.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$1.00M
10-Q · filed 2016-05-06
-$26.00M
derived: sum of 2 quarters · filed 2017-02-27
-$33.00M
derived: sum of 3 quarters · filed 2017-02-27
-$39.00M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$32.00M
derived: sum of 2 quarters · filed 2017-02-27
-$38.00M
derived: sum of 3 quarters · filed 2017-02-27
-$42.00M
10-K · filed 2017-02-27
2014-09-30-$7.00M
10-Q · filed 2015-11-04
-$7.01M
10-Q · filed 2014-11-05
-$13.00M
derived: sum of 2 quarters · filed 2015-11-04
-$17.00M
10-Q · filed 2015-11-04
-$16.94M
10-Q · filed 2014-11-05
-$22.15M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30-$6.00M
10-Q · filed 2015-08-05
-$5.11M
10-Q · filed 2014-08-04
-$10.00M
10-Q · filed 2015-08-05
-$9.93M
10-Q · filed 2014-08-04
-$15.15M
derived: sum of 3 quarters · filed 2016-02-24
-$18.54M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31-$4.00M
10-Q · filed 2015-05-08
-$4.82M
10-Q · filed 2014-05-07
-$9.15M
derived: sum of 2 quarters · filed 2016-02-24
-$12.54M
derived: sum of 3 quarters · filed 2016-02-24
-$17.52M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$5.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$8.54M
derived: sum of 2 quarters · filed 2016-02-24
-$13.52M
derived: sum of 3 quarters · filed 2016-02-24
-$18.00M
10-K · filed 2016-02-24
-$17.52M
10-K · filed 2014-02-25
2013-09-30-$3.39M
10-Q · filed 2014-11-05
-$8.38M
derived: sum of 2 quarters · filed 2014-11-05
-$12.85M
10-Q · filed 2014-11-05
-$16.47M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30-$4.99M
10-Q · filed 2014-08-04
-$9.46M
10-Q · filed 2014-08-04
-$13.08M
derived: sum of 3 quarters · filed 2015-02-25
-$17.55M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31-$4.48M
10-Q · filed 2014-05-07
-$8.09M
derived: sum of 2 quarters · filed 2015-02-25
-$12.56M
derived: sum of 3 quarters · filed 2015-02-25
-$18.05M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31-$3.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$8.09M
derived: sum of 2 quarters · filed 2015-02-25
-$13.57M
derived: sum of 3 quarters · filed 2015-02-25
-$18.00M
10-K · filed 2015-02-25
-$17.97M
10-K · filed 2013-02-27
2012-09-30-$4.47M
10-Q · filed 2013-10-31
-$9.96M
derived: sum of 2 quarters · filed 2013-10-31
-$14.38M
10-Q · filed 2013-10-31
-$17.77M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$5.49M
10-Q · filed 2013-08-01
-$9.91M
10-Q · filed 2013-08-01
-$13.30M
derived: sum of 3 quarters · filed 2014-02-25
-$16.89M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$4.42M
10-Q · filed 2013-05-08
$4.42M
10-Q · filed 2012-05-04
-$7.81M
derived: sum of 2 quarters · filed 2014-02-25
-$11.40M
derived: sum of 3 quarters · filed 2014-02-25
-$15.16M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31-$3.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$6.97M
derived: sum of 2 quarters · filed 2014-02-25
-$10.74M
derived: sum of 3 quarters · filed 2014-02-25
-$14.58M
10-K · filed 2014-02-25
$14.58M
10-K · filed 2012-02-23
2011-09-30-$3.59M
10-Q · filed 2012-11-06
-$7.35M
derived: sum of 2 quarters · filed 2012-11-06
-$11.19M
10-Q · filed 2012-11-06
-$6.57M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30-$3.77M
10-Q · filed 2012-08-01
-$7.61M
10-Q · filed 2012-08-01
-$2.98M
derived: sum of 3 quarters · filed 2013-02-27
-$5.70M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$3.84M
10-Q · filed 2012-05-04
-$3.84M
10-Q · filed 2011-05-09
$784.00K
derived: sum of 2 quarters · filed 2013-02-27
-$1.93M
derived: sum of 3 quarters · filed 2013-02-27
-$4.86M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31-$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$5.77M
derived: sum of 2 quarters · filed 2013-02-27
-$8.70M
derived: sum of 3 quarters · filed 2013-02-27
-$11.51M
10-K · filed 2013-02-27
2010-09-30-$2.71M
10-Q · filed 2011-11-04
-$5.65M
derived: sum of 2 quarters · filed 2011-11-04
-$8.45M
10-Q · filed 2011-11-04
$9.05M
derived: sum of 4 quarters · filed 2012-02-23
2010-06-30-$2.93M
10-Q · filed 2011-08-05
-$5.74M
10-Q · filed 2011-08-05
$11.77M
derived: sum of 3 quarters · filed 2012-02-23
$9.21M
derived: sum of 4 quarters · filed 2012-02-23
2010-03-31-$2.81M
10-Q · filed 2011-05-09
$14.70M
derived: sum of 2 quarters · filed 2012-02-23
$12.14M
derived: sum of 3 quarters · filed 2012-02-23
$9.89M
derived: sum of 4 quarters · filed 2012-02-23
2009-12-31$17.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
$14.95M
derived: sum of 2 quarters · filed 2012-02-23
$12.70M
derived: sum of 3 quarters · filed 2012-02-23
$10.16M
10-K · filed 2012-02-23
-$10.16M
10-K · filed 2010-03-01
2009-09-30-$2.56M
10-Q · filed 2010-11-08
-$4.81M
derived: sum of 2 quarters · filed 2010-11-08
-$7.34M
10-Q · filed 2010-11-08
-$9.71M
derived: sum of 4 quarters · filed 2011-02-28
2009-06-30-$2.25M
10-Q · filed 2010-08-09
-$4.79M
10-Q · filed 2010-08-09
-$7.16M
derived: sum of 3 quarters · filed 2011-02-28
-$9.32M
derived: sum of 4 quarters · filed 2011-02-28
2009-03-31-$2.54M
10-Q · filed 2010-05-10
-$4.91M
derived: sum of 2 quarters · filed 2011-02-28
-$7.07M
derived: sum of 3 quarters · filed 2011-02-28
-$9.22M
derived: sum of 4 quarters · filed 2011-02-28
2008-12-31-$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28
-$4.53M
derived: sum of 2 quarters · filed 2011-02-28
-$6.69M
derived: sum of 3 quarters · filed 2011-02-28
-$8.56M
10-K · filed 2011-02-28
2008-09-30-$2.16M
10-Q · filed 2009-11-05
-$4.32M
derived: sum of 2 quarters · filed 2009-11-05
-$6.20M
10-Q · filed 2009-11-05
2008-06-30-$2.16M
10-Q · filed 2009-08-05
-$4.04M
10-Q · filed 2009-08-05
2007-12-31-$9.11M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31